Tag: GRPN

Blue Horseshoe Stocks: MNKD, VRX Recaps & More

MannKind Corp. MNKD

We tagged MNKD a week ago today in our premarket report on May 4th, and wanted to circle back around this morning to go over the excellent performance the stock has recorded since then. At the time the stock had been looking like it wanted to rebound after crashing down to a bottom and our decision to mention it turned out to be timed perfectly.

In each of the past five sessions MNKD has registered higher highs and higher lows, continuing to gain back ground that it had lost in previous weeks. From last Thursday’s low of .688, the stock has gone on to reach a high of 1.88, which represents an increase of 173% while volume over the same period has been impressive. The stock traded its highest volume since 2014 yesterday, so we’re really eager to continue tracking the activity in MNKD.

Valeant Pharmaceuticals, Inc. VRX

Despite already showing us amazing single-session gains ranging from 380-3600% on Tuesday, which we recapped in yesterday’s premarket report, our options idea for the VRX chain, the Weekly $10.50-12 Calls saw even further advances once the session kicked off.

We’ve included the total possible intraday gains from yesterday’s session, as well as the overall gains from our observed lows on Tuesday morning.

$10.50 Calls – Daily Range: 1.43-2.36 – Daily Gain: 65% – Total Range: .40-2.36 – Two-Day Swing: 490%
$11 Calls – Daily Range: .92-1.99 – Daily Gain: 116% – Total Range: .18-1.99 – Two-Day Swing: 1005%
$11.50 Calls – Daily Range: .53-1.42 – Daily Gain: 68% – Total Range: .08-1.42 – Two-Day Swing: 1675%
$12 Calls – Daily Range: .29-.99 – Daily Gain: 241% – Total Range: .02-.99 – Two-Day Swing: 4850%

Even though it’s not even close to our only percentage gainer in the thousands, this round of options calls with VRX is certainly going down as one of our most solid picks of the year so far. Even if someone had only bought shares in VRX stock itself, they could have been up just over 22% on this two-day swing.

Groupon, Inc. GRPN

We want to place GRPN on recovery watch after noticing the stock coming up off a double-bottom, with a gap on the chart to fill to the upside, as you can see on the included snapshot.

We like to monitor plays in this position, so we’ll put it on our radars in the days and weeks ahead. Given the look of this chart, we’d classify this as relatively low-risk, low-reward in comparison one of our average plays.

Extended Watchlist:
DEST, LPSN, MSLI, SGMO, SYN, SYMX

Blue Horseshoe Stocks: Options Update, GALT Recap & More

Whole Foods Market, Inc. WFM – Options Update

We just wanted to circle back for our WFM options idea that we submitted last week. We designated contracts with a 02/17 expiration instead of weeklies to give our idea time to develop and it ended up being a good call. Our targets were the WFM 02/17 $30 and 30.50 Calls.

Yesterday WFM had a morning pullback which was followed by a nice reversal, and the stock ended up bulling its way into the close near its high of day. The calls we signaled last week had a significant move as a result. The $30 Calls ran from .14-.52 (+271%), while the $30.50’s exploded from .05-.21 (+320%). We are going to want to keep them on our radar for the rest of the week into expiration.

Key resistance is at the 200DMA and 50DMA of 30.38 and 30.76, respectively. If WFM can crack the latter, we may look to roll our strike price up and push out another week to contracts expiring next Friday- particularly, the WFM 02/24 $31 Calls.


Galectin Therapeutics, Inc. GALT

We’ve now witnessed quite a run from GALT over the past few weeks, validating our previous reports on the stock wherein we contested that a serious run-up appeared likely.

It began with our report on 01/12, in which we noted GALT’s ripening chart, and surmised that forthcoming gains of 100% were not out of the question. We observed a low of .935 subsequent to that followed by a nice 38% push to 1.29 leading into our most recent report on GALT last Friday.

In that report we had this to say “We feel these gains are sustainable if GALT can manage to crack past the current 200DMA at 1.32. As you can see on the included snapshot, the chart continues to bear the look of potential for even further increases“.

Yesterday GALT met those expectations nicely with a run to a new high of 1.85, which marks an overall increase from our observed low of 98%, falling just a hair shy of our initial speculations. Yet, our prediction seems to be coming full circle this morning as the stock is gearing up to fill its gap on the chart that we pointed out in our initial report. One more bullish push will get us into double-bagger territory for this idea, and the stock may well make a run well into the 2.00-range.

Green EnviroTech Holdings Corp. GETH – Recap

We were quite pleased with the performance of GETH following our featured report yesterday morning, as the stock provided traders with a pair of solid intraday swings amid an onslaught of volume.

Right from the opening bell, GETH shot up from .165 to the high of day at .235, marking an initial rip of 42% The stock subsequently pulled back to a daily low at .1514, before surging up once more to .215, matching the morning’s 42% gain exactly.

All of this useful volatility was accompanied by massive volume on the order of 39X the monthly average, or 19X the 3-month average. It represented an all-time record high for shares of GETH traded in a single session!

Yesterday we had identified .15 as the key support level that needed to hold in order to make GETH interesting, and our sentiments in that regard haven’t changed.

Extended Watchlist:
ONOV, GAHC, NNSR, BG, WIX, GRPN, EVOK,

Blue Horseshoe Stocks: BTCS Recap, EVOK & More

BTCS, Inc. BTCS

We caught BTCS on a routine scan yesterday morning after noticing some abnormal activity from the session prior. Our timing ended up being extremely fortuitous, with the stock making quite an impressive morning run.

From a low of .0013, it surged up as high as .0024 just prior to midday, for a healthy pop of 85% on almost ten times the three-month average volume. If BTCS can hold support at or above yesterday’s swing low, we’ll continue to be interested in the possibilities it may provide.

Evoke Pharma, Inc. EVOK

EVOK is another fresh play that we’re taking a look at for the first time this morning. The stock has recently fallen off of a cliff, as we’ve pointed out on the annotated chart below. Beginning with a massive gap-down earlier this month, followed by several sessions of backsliding which culminated in a new 52-week low (1.52) being set on Monday.

Yesterday’s bottom-bounce activity is what has us on alert. The stock is heavily oversold, and could be in line for a substantial rebound. We’ll want to be hanging around when that occurs, because even a return to the bottom of the chart gap at 3.50, from current levels, would spell an opportunity for significant gains.

Tempur Sealy International, Inc. TPX – Options Idea

TPX is fresh off an earnings beat this morning which has it gapping up into the $70-range. We’re going to signal a range of longer-term options ideas for us to track in the days and weeks to come. Our area of interest here is going to be the TPX 08/19 $70-80 Calls, giving us just over three weeks’ time to see a continued PPS recovery. 

Extended Watchlist:
SOULD, GYST, GRPN, EBIO, EPRS, WEYL
 NSRS(Potential Bottom Bouncer)

Blue Horseshoe Stocks: Options Roundup & More

Options Roundup

We produced three sets of options ideas in yesterday morning’s premarket report, and considering our recent track record with options plays, it should come as no surprise that we hit on some big gainers with all of them.

Petroleo Brasiliero SA (Petrobras) PBR

We’ve successfully come up with winning options ideas for PBR on so many occasions, we’ve lost count at this point. Our targeted contracts yesterday were the Weekly $5 and $5.50 Calls, and both sets recorded solid moves on the day.

For the $5’s we saw a nice run from .42-.77, an intraday swing of 83%, while the $5.50 Calls doubled that performance with a 166% pop from .12-.32. 

We mentioned that the idea could serve for swing trades into today, and it appears as if PBR’s gap up will extend the gains we’ve seen thus far, especially considering that oil is presently at its highest price in months. In addition to staying on top of those 5.50’s, we’ll explore the possibility of rolling up our strike price to the 6.00-level. We’ll just need to see the stock hold support at its previous resistance point of 5.72 on any early pullbacks.

__________

United Parcel Service, Inc. UPS

The next idea we came up with was to take a look at UPS April 8th $104 Calls, which we found attractive for a number of reasons that we listed in our report, and those contracts put up a top-notch performance as well.

They started out from a low of .47 and would end up hitting a daily high of 1.50; gains of up to 219% were there for the taking.

__________

SeaWorld Entertainment, Inc. SEAS

We were very interested in Seaworld’s PR concerning the halting of the Killer Whale breeding programs and theater show phase-out yesterday(>>View PR). The announcement was received well by the investing community, as well as the company seeing goodwill on social media for doing the right thing- at one point on Twitter, #Seaworld was trending in the Top 3 for the US in the wake of the news.

We set our sights on SEAS April 15th $18 Calls, and were met with an excellent intraday gain opportunity as they ran 150% from .40-1.00.

Sparta Commercial Services, Inc. SRCO

We also want to give ourselves a pat on the back for SRCO, which we included in yesterday’s extended watchlist. The stock made a respectable intraday move for us, to the tune of 60% as it traded in a range from .003-.0048 on roughly six times the 3-month average volume.

Bank of America Corp. BAC – Fresh Options Idea

BAC is currently gapping up in the premarket on news that the company will be increasing the scope of their share buyback program, and we’re going to signal a set of options contracts for observation to correspond with that. We’re going to be taking a look at BAC Weekly $13.50 Calls for a possible daytrade*.

*Don’t forget, trading weekly options contracts on a Friday is a very risky proposition, and is recommended for seasoned traders only.

Extended Watchlist:
DNR, CHK, WLL, XCO, GRPN, GDPM, LEGX, COTE(Possible bottom bouncer)

Blue Horseshoe Stocks: Potential Bottom-Plays & More

Solaris Power Cells, Inc. SPCL

We’ve got a news play hitting our scanner this morning in SPCL, and as it turns out, the chart is looking ripe for a nice move. As we’ve pointed out on the following snapshot, the stock is trading near a relative bottom, having just registered a new 52-week low just two weeks ago.

Our regular readers are well acquainted with our history of banking excellent gains off a good rebound play. SPCL could be next in line on that front, so we’ll keep a sharp eye on it to start the week.

In addition to trading near a bottom, we’re seeing signs of a very oversold stock with a lot of room to the upside:

PALM SPRINGS, Calif., July 13, 2015 (GLOBE NEWSWIRE) — Solaris Power Cells, Inc. the creators of the Solaris PESATM “Passive Electron Storage Array”™, (the “Company”) (OTCQB:SPCL)  the Board of Directors of Solaris Power Cells today announced the appointment of long-time energy policy leader Robert Foster to lead Solaris Energy Storage Advisory Board, effective July 10th 2015. >> FULL PR

OncoGenex Pharmaceuticals, Inc OGXI

OGXI announced this morning that one of its cancer treatments, currently in Phase III trials has passed rigorous criteria and
that trials for patients with non-small cell lung cancer will proceed as planned. The stock is gapping up in premarket trading, and we’re going to monitor its activity as the session commences.

BOTHELL, Wash. and VANCOUVER, British Columbia, July 13, 2015 /PRNewswire/ — OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that its Phase 3 ENSPIRIT trial evaluating custirsen in the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) is continuing as planned per the recommendation of an Independent Data Monitoring Committee>> FULL PR


Frontline, Ltd. FRO

We’ve got a long history with FRO that stretches all the way back to 2012. We tagged FRO in Thursday’s premarket report, after it hit a relative bottom of 2.21 on Wednesday. Our observed low following Thursday’s alert was 2.32, and on Friday we saw as the stock inched up to a high of 2.43. We’re going to be on the lookout for further gains; the stock is gapping up slightly in early trading this morning.

An added element to the story is an opinion article that came across the wires last week pertaining to the perceived undervaluation of FRO. It points to a potential longer-term uptrend in the cards, stating that while this year’s earnings growth is expected to top last year’s by more than 200%, that hasn’t really been reflected in the share price. We suggest our subscribers click the following link and give it a read >> VIEW ARTICLE

Extended Watchlist:
PSDV, GILT, FREE, GRPN, DANG, CLTX, DRYS

Get Our FREE Daily Reports!

SUBSCRIBE